Patents by Inventor Stephen Boyd

Stephen Boyd has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 10391275
    Abstract: Systems, devices and methods for draining and analyzing bodily fluids are disclosed in which a drainage assembly is configured to prevent negative pressure build-up. The drainage assembly generally includes a catheter which may include a drainage lumen, a reservoir, a venting mechanism in fluid communication with the drainage lumen and a positive pressure lumen, and a controller. The venting mechanism may further include a valve which is configured to maintain a closed position, as well as a vent in fluid communication with the valve, where the venting mechanism is configured to inhibit wetting of the vent from fluid within the drainage lumen.
    Type: Grant
    Filed: September 27, 2016
    Date of Patent: August 27, 2019
    Assignee: Potrero Medical, Inc.
    Inventors: Daniel R. Burnett, Rich Keenan, Dimitri Sokolov, Stephen Boyd, Martin Williams, Kondapavulur Venkateswara-Rao, Michelle Arney
  • Publication number: 20190259008
    Abstract: An online index of websites that leverages generic top-level domain extension names as an intuitive nomenclature with which to index websites using a website template or plug-in. The website template or plug-in and associated software accesses the consolidated data of the indexed websites into a virtual database and synchronizes the data to a user's hardware wallet which operates an exchange software program forming a decentralized exchange enabling transactions to be settled off-line and peer-to-peer which are then recorded onto a distributed ledger or block-chain.
    Type: Application
    Filed: March 23, 2019
    Publication date: August 22, 2019
    Inventor: Stephen Boyd Lindsey
  • Patent number: 10383817
    Abstract: An implant for insertion through a punctum and into a canalicular lumen of a patient. The implant includes a matrix of material, a therapeutic agent dispersed in the matrix of material, a sheath disposed over a portion of the matrix of material and configured to inhibit the therapeutic agent from being released from the matrix of material into the canalicular lumen and to allow the therapeutic agent to be released from a surface of the matrix of material to a tear film, and a retention structure configured to retain the implant within the canalicular lumen.
    Type: Grant
    Filed: December 22, 2017
    Date of Patent: August 20, 2019
    Assignee: Mati Therapeutics Inc.
    Inventors: Eugene de Juan, Jr., Stephen Boyd, Cary Reich, Alan Rapacki, Hanson S Gifford, Mark Deem
  • Patent number: 10350004
    Abstract: The present invention provides devices and methods for decalcifying an aortic valve. The methods and devices of the present invention break up or obliterate calcific deposits in and around the aortic valve through application or removal of heat energy from the calcific deposits.
    Type: Grant
    Filed: July 18, 2016
    Date of Patent: July 16, 2019
    Assignee: Twelve, Inc.
    Inventors: Hanson Gifford, III, Mark Deem, Stephen Boyd
  • Publication number: 20190201348
    Abstract: A dosage form comprising a capsule containing one or more tablets of 5-aminosalicylic acid or a salt thereof as an active ingredient where each of the one or more tablets is enterically coated is disclosed.
    Type: Application
    Filed: March 11, 2019
    Publication date: July 4, 2019
    Inventors: Emma Boyd, Deborah Leigh Caldwell, Catherine Coulter, Ryan Loughlin, Stephen McCullagh
  • Patent number: 10320162
    Abstract: Motor control centers have units or buckets with one or more sliding shutters that controllably block access to a stab isolation port based on position of the operator disconnect handle using attached cams that slide the shutter right and left. A front panel of the unit or bucket may also be configured to pivot out about a long axis associated with a bottom long side thereof.
    Type: Grant
    Filed: June 13, 2018
    Date of Patent: June 11, 2019
    Assignee: Eaton Intelligent Power Limited
    Inventors: Stephen William Oneufer, Robert Allan Morris, Daniel Boyd Kroushl
  • Patent number: 10300014
    Abstract: An implant for insertion through a punctum and into a canalicular lumen of a patient. The implant includes a matrix of material, a therapeutic agent dispersed in the matrix of material, a sheath disposed over a portion of the matrix of material and configured to inhibit the therapeutic agent from being released from the matrix of material into the canalicular lumen and to allow the therapeutic agent to be released from a surface of the matrix of material to a tear film, and a retention structure configured to retain the implant within the canalicular lumen.
    Type: Grant
    Filed: October 23, 2018
    Date of Patent: May 28, 2019
    Assignee: Mati Therapeutics Inc.
    Inventors: Eugene de Juan, Jr., Cary Reich, Stephen Boyd, Hanson S. Gifford, Mark Deem, Alan Rapacki
  • Publication number: 20190105265
    Abstract: A solid drug core insert can be manufactured by injecting a liquid mixture comprising a therapeutic agent and a matrix precursor into a sheath body. The injection can be conducted at subambient temperatures. The mixture is cured to form a solid drug-matrix core. The therapeutic agent can be a liquid at about room temperature that forms a dispersion of droplets in the matrix material. A surface of the solid drug core is exposed, for example by cutting the tube, and the exposed surface of the solid drug core releases therapeutic quantities of the therapeutic agent when implanted into the patient. In some embodiments, the insert body inhibits release of the therapeutic agent, for example with a material substantially impermeable to the therapeutic agent, such that the therapeutic quantities are released through the exposed surface, thereby avoiding release of the therapeutic agent to non-target tissues.
    Type: Application
    Filed: October 11, 2018
    Publication date: April 11, 2019
    Applicant: Mati Therapeutics Inc.
    Inventors: Deepank Utkhede, JR., Robert Shimizu, Rachna Jain, Stephen Boyd, Hanson S Gifford, Eugene De Juan, Cary Reich
  • Publication number: 20190105198
    Abstract: A therapeutic system comprises an ocular insert placed on a region outside an optical zone of an eye. The ocular insert comprises two structures: a first skeletal structure and a second cushioning structure. The first structure functions as a skeletal frame which maintains positioning of the implant along the anterior portion of the eye and provides support to the second, cushioning structure. This first structure maintains the attachment of the therapeutic system to the anterior portion of the eye for at least thirty days. In some embodiments the first structure remains a constant size and shape, e.g. a ring shape, a ring with haptics, or a curvilinear ring that is confined to and restrainingly engages the inferior and superior conjunctival fornices so as to retain the implant within the tear fluid and/or against the tissues of the eye.
    Type: Application
    Filed: June 8, 2018
    Publication date: April 11, 2019
    Inventors: Yair Alster, Eugene de Juan, JR., Cary J. Reich, Stephen Boyd, David Sierra, Jose D. Alejandro, K. Angela Macfarlane, Douglas Sutton
  • Publication number: 20190066066
    Abstract: An online index of websites that leverages generic top-level domain extension names as an intuitive nomenclature with which to index websites using a website template or plug-in. The website template or plug-in and associated software accesses the consolidated data of the indexed websites into a virtual database and forms a distributed ledger or block-chain enabling transactions to be settled peer to peer on a de-centralized exchange.
    Type: Application
    Filed: March 12, 2018
    Publication date: February 28, 2019
    Inventor: Stephen Boyd Lindsey
  • Publication number: 20190054018
    Abstract: An implant for insertion through a punctum and into a canalicular lumen of a patient. The implant includes a matrix of material, a therapeutic agent dispersed in the matrix of material, a sheath disposed over a portion of the matrix of material and configured to inhibit the therapeutic agent from being released from the matrix of material into the canalicular lumen and to allow the therapeutic agent to be released from a surface of the matrix of material to a tear film, and a retention structure configured to retain the implant within the canalicular lumen.
    Type: Application
    Filed: October 23, 2018
    Publication date: February 21, 2019
    Applicant: Mati Therapeutics Inc.
    Inventors: Eugene de Juan, JR., Cary Reich, Stephen Boyd, Hanson S. Gifford, Mark Deem, Alan Rapacki
  • Publication number: 20190054017
    Abstract: An implant for insertion into a punctum of a patient comprises a body. The body has a distal end, a proximal end, and an axis therebetween. The distal end of the body is insertable distally through the punctum into the canalicular lumen. The body comprises a therapeutic agent included within an agent matrix drug core. Exposure of the agent matrix to the tear fluid effects an effective therapeutic agent release into the tear fluid over a sustained period. The body has a sheath disposed over the agent matrix to inhibit release of the agent away from the proximal end. The body also has an outer surface configured to engage luminal wall tissues so as to inhibit expulsion when disposed therein. In specific embodiments, the agent matrix comprises a non-bioabsorbable polymer, for example silicone in a non-homogenous mixture with the agent.
    Type: Application
    Filed: October 23, 2018
    Publication date: February 21, 2019
    Applicant: Mati Therapeutics Inc.
    Inventors: Eugene de Juan, Cary Reich, Stephen Boyd, Hanson S. Gifford, Mark Deem
  • Publication number: 20190001007
    Abstract: UV hard-surface disinfection system that is able to disinfect the hard surfaces in a room, while minimizing missed areas due to shadows by providing multiple UV light towers that can be placed in several areas of a room such that shadowed areas are eliminated and that can be transported by a cart that is low to the ground such that the towers may be loaded and unloaded easily by a single operator. The system is able to be controlled remotely, such that during activation of the system, no operator is present, and to automatically cut power to all towers in the event that a person enters the room.
    Type: Application
    Filed: September 7, 2018
    Publication date: January 3, 2019
    Applicant: Surfacide, LLC
    Inventors: Waldemar John Lyslo, Mark Howard Schwartz, Stephen Boyd Pettis
  • Patent number: 10100511
    Abstract: A dowel supporting device that includes a substantially hollow tube having a top end and a bottom end. An opening may be formed at the top end and a base may be formed at the bottom end. The base of the dowel supporting device may be fastened to a concrete deck. Concrete may be poured into the concrete deck. When dowels are ready to be used, the dowels may be inserted and secured to the dowel supporting device. A cap or thin sealed covering may be placed at the top end of the hollow tube to prevent infiltration of concrete into the tube during a concrete pour. The cap or thin sealed covering may include a raised portion of material which aids in locating the hollow tube after a concrete slab cures around it. A dowel tube extender may be provided which extends a hollow tube to accommodate different concrete slab thicknesses.
    Type: Grant
    Filed: December 1, 2017
    Date of Patent: October 16, 2018
    Inventors: Stephen Boyd, Joseph Accetta
  • Patent number: 10092665
    Abstract: UV hard-surface disinfection system that is able to disinfect the hard surfaces in a room, while minimizing missed areas due to shadows by providing multiple UV light towers that can be placed in several areas of a room such that shadowed areas are eliminated and that can be transported by a cart that is low to the ground such that the towers may be loaded and unloaded easily by a single operator. The system is able to be controlled remotely, such that during activation of the system, no operator is present, and to automatically cut power to all towers in the event that a person enters the room.
    Type: Grant
    Filed: September 8, 2017
    Date of Patent: October 9, 2018
    Assignee: Surfacide, LLC
    Inventors: Waldemar John Lyslo, Mark Howard Schwartz, Stephen Boyd Pettis
  • Publication number: 20180193133
    Abstract: A therapeutic lens for the treatment of an epithelial defect comprises a layer of therapeutic material disposed over the stroma and/or Bowman's membrane to inhibit water flow from the tear liquid to the stroma and/or Bowman's membrane, such that corneal deturgescence can be restored to decrease corneal swelling and light scattering. The layer may cover and protect nerve fibers to decrease pain. The layer may comprise an index of refraction to inhibit light scatter from an anterior surface of the stroma and/or Bowman's membrane. The lens may comprise a curved anterior surface that provides functional vision for the patient when the epithelium regenerates. The layer of therapeutic material can be positioned on the eye in many ways, for example with a spray that is cured to adhere the layer to the exposed surface of the stroma and/or Bowman's membrane.
    Type: Application
    Filed: March 9, 2018
    Publication date: July 12, 2018
    Inventors: EUGENE DE JUAN, JR., CARY J. REICH, STEPHEN BOYD, YAIR ALSTER, DAVID SIERRA, HANSON S. GIFFORD, JOSE D. ALEJANDRO, RICHARD L. LINDSTROM, K. ANGELA MACFARLANE, DOUGLAS SUTTON, JOHN ANTHONY SCHOLL
  • Publication number: 20180177458
    Abstract: Systems, devices and methods for sensing physiologic data and draining and analyzing bodily fluids are described which are capable of sensing physiologic data based on sensors incorporated into a catheter adapted to reside in any of a urinary tract, gastrointestinal tract, rectal location, pre-peritoneal, pleural space or other body cavity. The devices aid emptying of the bladder, measure urine output and various urine parameters such as oxygen tension, urine conductance and urine specific gravity, monitor renal function, analyze urine parameters, including urine content, including the presence of infection, and track and/or control fluid administration.
    Type: Application
    Filed: March 1, 2017
    Publication date: June 28, 2018
    Applicant: Potrero Medical, Inc.
    Inventors: Daniel R. BURNETT, Evan S. LUXON, Rich KEENAN, Marcie HAMILTON, Saheel SUTARIA, Mark ZIEGLER, Alex YEE, Griffeth TULLY, Christina SKIELLER, Stephen BOYD
  • Publication number: 20180177634
    Abstract: A comfortable insert comprises a retention structure sized for placement under the eyelids and along at least a portion of conjunctival sac of the upper and lower lids of the eye. The retention structure resists deflection when placed in the conjunctival sac of the eye and to guide the insert along the sac when the eye moves. The retention structure can be configured in many ways to provide the resistance to deflection and may comprise a hoop strength so as to urge the retention structure outward and inhibit movement of the retention structure toward the cornea. The insert may move rotationally with deflection along the conjunctival sac, and may comprise a retention structure having a cross sectional dimension sized to fit within folds of the conjunctiva. The insert may comprise a release mechanism and therapeutic agent to release therapeutic amounts of the therapeutic agent for an extended time.
    Type: Application
    Filed: February 26, 2018
    Publication date: June 28, 2018
    Inventors: Eugene de Juan, JR., Yair Alster, Cary J. Reich, K. Angela Macfarlane, Janelle Chang, Stephen Boyd, David Sierra, Jose D. Alejandro, Douglas Sutton, Alexander J. Gould
  • Patent number: 10004636
    Abstract: A therapeutic system comprises an ocular insert placed on a region outside an optical zone of an eye. The ocular insert comprises two structures: a first skeletal structure and a second cushioning structure. The first structure functions as a skeletal frame which maintains positioning of the implant along the anterior portion of the eye and provides support to the second, cushioning structure. This first structure maintains the attachment of the therapeutic system to the anterior portion of the eye for at least thirty days. In some embodiments the first structure remains a constant size and shape, e.g. a ring shape, a ring with haptics, or a curvilinear ring that is confined to and restrainingly engages the inferior and superior conjunctival fornices so as to retain the implant within the tear fluid and/or against the tissues of the eye.
    Type: Grant
    Filed: August 5, 2016
    Date of Patent: June 26, 2018
    Assignee: ForSight Vision5, Inc.
    Inventors: Yair Alster, Eugene de Juan, Jr., Cary J. Reich, Stephen Boyd, David Sierra, Jose D. Alejandro, K. Angela Macfarlane, Douglas Sutton
  • Publication number: 20180133150
    Abstract: An implant for insertion through a punctum and into a canalicular lumen of a patient. The implant includes a matrix of material, a therapeutic agent dispersed in the matrix of material, a sheath disposed over a portion of the matrix of material and configured to inhibit the therapeutic agent from being released from the matrix of material into the canalicular lumen and to allow the therapeutic agent to be released from a surface of the matrix of material to a tear film, and a retention structure configured to retain the implant within the canalicular lumen.
    Type: Application
    Filed: December 22, 2017
    Publication date: May 17, 2018
    Inventors: Eugene de Juan, JR., Stephen Boyd, Cary Reich, Alan Rapacki, Hanson S. Gifford, Mark Deem